UPC APP 58035/2024

24. Okt. 2024·EP4201327 +1 more: FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Verfahrensdetails: Status
Written Phase
Verfahrensart
Allgemein
Kategorie
Kostenfestsetzungen
Parteien: Kläger
Insulet Corporation
Vertreter: Marc Grunwald
Beklagte
A. Menarini Diagnostics s.r.l.
Vertreter: Martin Kohler
Division: Milan LD
Richter: Pierluigi Perrotti
Alima Zana
Anna-Lena Klein
Uwe Schwengelbeck
Technology: Packaging & Conveying
Sprache: English
Erste Entscheidung: 30. Dez. 2024

Entscheidungen

2024-12-30
AbgewiesenKostenGeneric application
Milan Local Division dismissed Insulet Corporation's application for a cost decision following the rejection of EOFLOW Co. Ltd.'s intervention request in PI proceedings (EP 4 201 327). The court found the application inadmissible: a cost decision under R. 150 RoP requires a prior decision on costs in principle under R. 118.5 RoP. The order rejecting the intervention (1 October 2024) contained no such costs-in-principle decision, so the cost-determination application lacked the prerequisite under R. 156(e) RoP. Insulet was invited to resubmit once a costs award decision was obtained.
Rechtsfragen:Prerequisite of costs-in-principle decision for cost determination application (R. 150, 156 RoP)Cost decision following rejection of intervention request

Dokumente

Dokumenttitel	Datum	Öffentlich
Headnote-and-Keywords	2025-01-08	Nicht öffentlich
Outcome of the Order	2024-12-30	Nicht öffentlich
finale order 30 December 2024	2024-12-30	Öffentlich
rule 152 ROP	2024-11-11	Nicht öffentlich
Receipt	2024-10-24	Nicht öffentlich
Application for Cost Decision	2024-10-24	Nicht öffentlich
Exhibit PS-C01	2024-10-24	Nicht öffentlich